Aaron Wealth Advisors
RVMD icon

Aaron Wealth Advisors’s Revolution Medicines RVMD Stock Holding History

Aaron Wealth Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$568K Buy
2,766
+96
+4% +$19K 0.03% 406
2026
Q2 		$500K Buy
2,670
+244
+10% +$35.6K 0.03% 420
2026
Q1 		$236K Buy
+2,426
New +$245K 0.01% 628

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak Pty Ltd
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Aaron Wealth Advisors's RVMD Position: Q3 2026 in Review

Aaron Wealth Advisors increased its Revolution Medicines (RVMD) stake by 3.6% in Q3 2026, buying an estimated $19K and bringing the position to 2,766 shares worth $568K. The position accounts for 0.03% of the portfolio, ranked #406.

Aaron Wealth Advisors first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Aaron Wealth Advisors held 2,766 shares of Revolution Medicines worth $568K as of Q3 2026.
  • Aaron Wealth Advisors bought 96 Revolution Medicines shares in Q3 2026, an estimated $19K.
  • Revolution Medicines made up 0.03% of Aaron Wealth Advisors's portfolio in Q3 2026, its #406 holding.
  • Aaron Wealth Advisors first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.